Context.—Epidermal growth factor receptor (EGFR) mutations have been identified as
predictors of response to EGFR tyrosine kinase inhibitors in non–small cell lung cancer …

Purpose: EGFR gene mutations and increased EGFR copy number have been associated
with favorable response to epidermal growth factor receptor (EGFR) tyrosine kinase …

Lung cancer is one of the leading causes of death with one of the lowest survival rates.
However, a subset of lung cancer patients who are of Asian origin and carry somatic …

Purpose Some studies have shown that epidermal growth factor receptor (EGFR) mutations
can be heterogeneously distributed in individual tumors. In this study, we re-evaluated the …

Purpose EGFR mutations underlie the sensitivity of lung cancers to erlotinib and gefitinib
and can occur in any patient with this illness. Here we examine the frequency of EGFR …

Mutation in the epidermal growth factor receptor (EGFR) is frequently seen in non‐small cell
lung cancers (NSCLCs), especially in Asian females with adenocarcinoma. The frequency of …

Introduction Epidermal growth factor receptor (EGFR) mutations are strong determinants of
tumor response to EGFR tyrosine kinase inhibitors in non-small cell lung cancers (NSCLCs) …

Lung cancers with an epidermal growth factor receptor (EGFR) gene mutation account for~
40% of adenocarcinomas in East Asians and~ 15% of those in Caucasians and African …

The epidermal growth factor receptor (EGFR) has emerged as an attractive therapeutic
target for patients with non–small-cell lung cancer (NSCLC). However, despite its almost …

OBJECTIVE: Epidermal growth factor receptor is involved in the pathogenesis of non-small
cell lung cancer and has recently emerged as an important target for molecular therapeutics …